Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5219]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell...
Dr Laurie Sehn - University of British Columbia, Vancouver, Canada
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )
9 Jan 2012
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI...
Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765 ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )
19 Dec 2011
New data on aggressive B cell lymphoma
Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA
New data on aggressive B cell lymphoma ( Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA )
19 Dec 2011
Update on the phase III VISTA trial
Dr Jesus San Miguel – University Hospital of Salamanca, Spain
Update on the phase III VISTA trial ( Dr Jesus San Miguel – University Hospital of Salamanca, Spain )
19 Dec 2011
Treatment of breast cancer as a chronic disease
Dr Vered Stearns - John Hopkins Medicine, Baltimore, USA
Treatment of breast cancer as a chronic disease ( Dr Vered Stearns - John Hopkins Medicine, Baltimore, USA )
16 Dec 2011
Everolimus improved PFS in advanced hormone receptor positive breast cancer
Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA
Everolimus improved PFS in advanced hormone receptor positive breast cancer ( Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA )
16 Dec 2011
Anaemia management update: blood transfusion and ESA use in oncology
Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue...
Anaemia management update: blood transfusion and ESA use in oncology ( Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue and Prof Donat Spahn )
15 Dec 2011
Translational research and proteasome inhibitors in multiple myeloma
Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA
Translational research and proteasome inhibitors in multiple myeloma ( Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2011
Advances in the treatment of T-cell lymphoma
Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael...
Advances in the treatment of T-cell lymphoma ( Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael Pfreundschuh and Prof Wyndham Wilson )
6 Dec 2011
Key research from the 9th International Workshop for Lymphoma
Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael...
Key research from the 9th International Workshop for Lymphoma ( Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael Pfreundschuh and Prof Wyndham Wilson )
6 Dec 2011
Active angiogenesis drugs in development
Prof Bradley Monk – University of California Irvine, USA
Active angiogenesis drugs in development ( Prof Bradley Monk – University of California Irvine, USA )
24 Nov 2011
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast...
Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer ( Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA )
24 Nov 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation